You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Claims for Patent: 11,091,430

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,091,430

Title:	Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
Abstract:	This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula:
Inventor(s):	Anderson Eric, Jiang Xin, Visnick Melean
Assignee:	REATA PHARMACEUTICALS, INC.
Application Number:	US16786429
Patent Claims:	2. The method of claim 1 , wherein the bond joining carbon 9 and carbon 11 of the compound is a double bond.3. The method of claim 1 , wherein the bond joining carbon 9 and carbon 11 of the compound is a single bond.4. The method of claim 1 , wherein said neurodegenerative disease is selected from the group consisting of Parkinson's disease claim 1 , Alzheimer's disease claim 1 , multiple sclerosis (MS) claim 1 , Huntington's disease and amyotrophic lateral sclerosis.5. The method of claim 4 , wherein said neurodegenerative disease is Alzheimer's disease.6. The method of claim 4 , wherein said neurodegenerative disease is MS.7. The method of claim 1 , wherein the compound is administered systemically.8. The method of claim 7 , wherein the compound is administered intravenously claim 7 , intra-arterially claim 7 , intramuscularly claim 7 , intraperitoneally claim 7 , subcutaneously or orally.9. The method of claim 1 , wherein the effective amount is 0.1-1000 mg/kg.10. The method of claim 9 , wherein the effective amount is administered in a single dose per day.11. The method of claim 9 , wherein the effective amount is administered in two or more doses per day.13. The method of claim 12 , wherein the bond joining carbon 9 and carbon 11 of the compound is a double bond.14. The method of claim 12 , wherein the bond joining carbon 9 and carbon 11 of the compound is a single bond.16. The method of claim 15 , wherein the bond joining carbon 9 and carbon 11 of the compound is a double bond.17. The method of claim 15 , wherein the bond joining carbon 9 and carbon 11 of the compound is a single bond.19. The method of claim 18 , wherein the bond joining carbon 9 and carbon 11 of the compound is a double bond.20. The method of claim 18 , wherein the bond joining carbon 9 and carbon 11 of the compound is a single bond.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.